Evaluation of safety and immunogenicity of HNVAC, an MDCK-based H1N1 pandemic influenza vaccine, in Phase I single centre and Phase II/III multi-centre, double-blind, randomized, placebo-controlled, parallel assignment studies

✍ Scribed by Basavaraj, V.H.; Sampath, G.; Hegde, Nagendra R.; Mohan, V. Krishna; Ella, Krishna M.

• Book ID: 124142701
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 320 KB
• Volume: 32
• Category: Article
• ISSN: 0264-410X
• DOI: 10.1016/j.vaccine.2014.05.039